Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 25%Low 3 · 75%Moderate 0 · 0%High 0 · 0%

Major adverse events

Desmopressin plus alpha‐blocker showed no clear difference in major adverse events compared with alpha‐blocker (low certainty).

1 finding from 1 review

Desmopressin for treating nocturia in men 2017 · Cochrane Headline outcomes only
RR 0.3 [0.01, 7.32]
3 studies · 402 participants
Low

Minor adverse events

It is very uncertain whether desmopressin plus alpha‐blocker changes minor adverse events compared with alpha‐blocker (very low certainty).

1 finding from 1 review

Desmopressin for treating nocturia in men 2017 · Cochrane Headline outcomes only
RR 1.6 [0.15, 16.82]
3 studies · 402 participants
Very low

Major adverse events

1 finding from 1 review

Desmopressin for treating nocturia in men 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 427 participants
Low

Minor adverse events

Desmopressin plus alpha‐blocker may leads to lower minor adverse events compared with alpha‐blocker plus anticholinergic (low certainty).

1 finding from 1 review

Desmopressin for treating nocturia in men 2017 · Cochrane Headline outcomes only
RR 0.22 [0.05, 0.98]
1 study · 427 participants
Low